American Healthcare REIT (NYSE:AHR) Price Target Raised to $27.00 at Truist Financial

American Healthcare REIT (NYSE:AHR) had its price objective hoisted by investment analysts at Truist Financial from $22.00 to $27.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s price target would indicate a potential upside of 4.37% from the company’s current price.

AHR has been the topic of a number of other reports. JMP Securities increased their price target on shares of American Healthcare REIT from $18.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday. Morgan Stanley increased their target price on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. Bank of America lifted their target price on shares of American Healthcare REIT from $19.00 to $27.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Finally, KeyCorp upped their price target on shares of American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a research report on Monday. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $22.50.

American Healthcare REIT Stock Performance

NYSE:AHR traded up $0.46 during trading hours on Friday, hitting $25.87. The stock had a trading volume of 1,058,451 shares, compared to its average volume of 1,292,174. The company has a 50 day simple moving average of $19.24 and a two-hundred day simple moving average of $15.97. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.60. American Healthcare REIT has a one year low of $12.63 and a one year high of $26.29.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.28). American Healthcare REIT had a negative return on equity of 2.20% and a negative net margin of 1.99%. The company had revenue of $504.60 million during the quarter, compared to the consensus estimate of $506.55 million. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. On average, equities research analysts anticipate that American Healthcare REIT will post 1.28 EPS for the current fiscal year.

Institutional Investors Weigh In On American Healthcare REIT

Hedge funds and other institutional investors have recently modified their holdings of the stock. Principal Financial Group Inc. purchased a new stake in American Healthcare REIT during the 1st quarter valued at approximately $88,504,000. Centersquare Investment Management LLC purchased a new position in American Healthcare REIT during the first quarter valued at $63,269,000. V3 Capital Management L.P. bought a new stake in American Healthcare REIT in the 1st quarter valued at $42,337,000. Goldentree Asset Management LP purchased a new stake in American Healthcare REIT in the 1st quarter worth $22,125,000. Finally, Russell Investments Group Ltd. purchased a new position in shares of American Healthcare REIT during the first quarter valued at about $20,381,000. 16.68% of the stock is currently owned by hedge funds and other institutional investors.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.